A New Drug in Development for Negative Symptoms

Slideshow

Is an effective, well-tolerated treatment for the negative symptoms of schizophrenia on the horizon?

View the slides in PDF format.

Related Videos
Experts on MDD.
Experts on MDD.
Related Content

From the Pages of Psychiatric Times: September 2023

September 30th 2023

Here's to a Psychedelic Revolution

April 9th 2022

Psychiatry in the News: September 2023

September 29th 2023

Blue Light Blockers: A Behavior Therapy for Mania

October 7th 2021

NDA Submitted for Investigational Muscarinic Antipsychotic in the Treatment of Schizophrenia

September 28th 2023

Topline Phase 2 Data Support Efficacy, Tolerability, and Favorable Safety of Treatment for PTSD

September 26th 2023

From the Pages of Psychiatric Times: September 2023

September 30th 2023

Here's to a Psychedelic Revolution

April 9th 2022

Psychiatry in the News: September 2023

September 29th 2023

Blue Light Blockers: A Behavior Therapy for Mania

October 7th 2021

NDA Submitted for Investigational Muscarinic Antipsychotic in the Treatment of Schizophrenia

September 28th 2023

Topline Phase 2 Data Support Efficacy, Tolerability, and Favorable Safety of Treatment for PTSD

September 26th 2023

From the Pages of Psychiatric Times: September 2023

September 30th 2023

Here's to a Psychedelic Revolution

April 9th 2022

Psychiatry in the News: September 2023

September 29th 2023

Blue Light Blockers: A Behavior Therapy for Mania

October 7th 2021

NDA Submitted for Investigational Muscarinic Antipsychotic in the Treatment of Schizophrenia

September 28th 2023

Topline Phase 2 Data Support Efficacy, Tolerability, and Favorable Safety of Treatment for PTSD

September 26th 2023
© 2023 MJH Life Sciences

All rights reserved.